Abiopharma

🔍 Fuchs Charles S. (Executive)

Company: Erasca, Inc. (ERAS)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1,300,000 shares of Stock option (right to buy) at $18.12 per share (Derivative)
  Date: 2026-08-10 | Code: A | Expires: 2036-08-09 | Exercise: 2027-08-10 | equity_swap_involved: false | shares_owned_after: 1,300,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The reported option award was granted in connection with the Reporting Person's commencement of employment. Of the total option award, 21,480 shares were granted under the Issuer's 2021 Incentive Award Plan, with a portion intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code to the extent permitted by law. The remaining 1,278,520 shares were granted as a nonqualified stock option under the Issuer's 2026 Employment Inducement Incentive Award Plan.
• F2: The reported option award vests as follows: 25% of the shares subject to the option will vest on the first anniversary of the date of grant, and the remaining 75% of the shares will vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.